Neurologic Medication Costs: Direct-to-Consumer Vs. Commercial Insurance

A study compares the costs of neurologic medications for patients with commercial insurance versus those paying out-of-pocket, highlighting potential disparities in access to affordable care. The lack of comments suggests a lack of strong reaction or discussion around the findings.

Snapshot generated from the HN discussion